Global Blood Therapeutics CMO Eleanor Ramos retires
Dr. Ramos, an industry veteran with with more than 20 years of experience in the biotechnology and pharmaceutical industries, oversees Global Blood Therapeutics' clinical development and medical affairs.
Prior to joining Global Blood Therapeutics, Dr. Ramos served as chief medical officer of Theraclone Sciences where she led the development of monoclonal antibody therapies for viral diseases.
Prior to Theraclone, she held the role of senior vice president and chief medical officer at ZymoGenetics.
Dr. Ramos also led significant clinical research and development initiatives while at Bristol-Myers Squibb and Roche Global Development. She held faculty appointments at Harvard Medical School, the University of Florida, Yale University and the University of California, San Francisco.
Dr. Ramos began her medical career as an academic transplant nephrologist following completion of medical and subspecialty training at Tufts University and Brigham & Women's Hospital.
Dr. Ramos holds an M.D. from Tufts University School of Medicine and completed her training in transplant nephrology at the Brigham and Women's Hospital. ■
LATEST MOVES FROM California
- Impax Laboratories appoints Paul M. Bisaro as CEO
- Retrophin names John A. Orwin to board
- Intel appoints two to board
- Walt Disney Company extends CEO's contract to 2019
- Ekso Bionics adds Howard Palefsky to board
More inside POST